Position in TBPH
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$683,331
-$1,507,310 QoQ
Shares Held
42,103
-64.0% QoQ
Ownership
0.082%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
7 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in TBPH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Man Group plc holds $985,463,032 across 125 Biotechnology names. TBPH ranks #73 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
315,212 | $243,545,399 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
236,798 | $105,739,778 | |
| 3 | INCY |
Incyte Corp
|
930,171 | $87,547,693 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
232,369 | $76,883,931 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
241,922 | $71,843,576 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
275,270 | $26,770,006 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
135,212 | $25,561,828 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
142,271 | $24,046,644 |
All Filings in TBPH
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $683,331 | 42,103 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,190,641 | 117,084 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,164,948 | 79,791 | Shares | Defined | 2025-11-14 | |
| 2024-12-31 | $97,186 | 10,328 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $202,942 | 25,179 | Shares | Defined | 2024-11-14 | |
| 2024-03-31 | $90,605 | 10,101 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $386,341 | 34,372 | Shares | Defined | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||